Bridgewater, MA, United States of America

John J Boyce, Iv

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John J Boyce, Iv: Innovator in Nucleic Acid Target Representation

Introduction

John J Boyce, Iv is a notable inventor based in Bridgewater, MA (US). He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid analysis. His innovative methods have the potential to enhance the accuracy and efficiency of multi-target analyses.

Latest Patents

John J Boyce, Iv holds a patent for "Methods of equalizing representation levels of nucleic acid targets." This patent provides methods aimed at reducing the range of representation levels of nucleic acid targets. The techniques are especially beneficial for applications such as single molecule sequencing, heterozygous genotyping, and pathogen diagnosis. The patent outlines two general methods: Method 1 involves adjusting the starting concentrations of probes, while Method 2 entails 'binning' target-specific probes based on similar representation levels. Each subset of corresponding targets can then be extracted using separate portions of the sample.

Career Highlights

Throughout his career, John J Boyce, Iv has been associated with Helicos Biosciences Corporation, where he has contributed to advancements in genomic technologies. His work has focused on improving the methodologies used in nucleic acid analysis, which is crucial for various applications in research and diagnostics.

Collaborations

John J Boyce, Iv has collaborated with Timothy D Harris, among others, to further enhance the development of innovative solutions in the field of molecular biology.

Conclusion

John J Boyce, Iv is a distinguished inventor whose work in nucleic acid target representation has the potential to significantly impact the field of molecular biology. His contributions continue to pave the way for advancements in genomic analysis and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…